The FDA has approved Atzumi (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.

DHE is a migraine-specific acute medication first approved in 1946. The FDA's approval of the nasal powder formulation, ...

Nasal spray tech facilitates the delivery of proteins, small-molecule drugs and peptides. Credit: 1777177/Shutterstock. The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal ...

Currently, intranasal vaccine efficacy is evaluated based on the measurement of polyclonal antibody titers in nasal lavage fluid ... overall sequence identity of at least 95% from the signal peptide ...

You want it to stay in the nose". Nicola ended the video by saying it would "change your life" if you administered the nasal spray in this way. Symptoms are usually worse between late March and ...

They had given patients oral supplements of vitamin D to reduce nasal inflammation and reverse the loss of the sense of smell the inflammation often causes. "It helped zero of 28 people," she said.

Spray it ain’t so! It’s bad enough you’re brushing your teeth all wrong — now it turns out you’ve also been abusing your nasal spray. “I was yesterday years old when I learned there ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

Most products come in a hand-operated pump bottle or squeeze bottle. Knowing how to use a nasal spray is important, as doing it incorrectly could affect the dose you receive. There are many OTC and ...

Zavegepant 10 mg nasal spray provided rapid and safe relief from acute migraine attacks but did not exhibit long-term superiority over oral calcitonin gene-related peptide receptor antagonists.

This condition occurs when the nasal passages become dependent on the spray to remain open, leading to a vicious cycle of usage and worsening symptoms. Frequent and prolonged use of decongestants can ...

The study is published in Nature Communications. During the early COVID-19 pandemic, this platform enabled the rapid development of a nasal spray vaccine in collaboration with mainland China's ...